glp 1 receptor agonist GLP-1 Agonists GLP-1 Receptor Agonists in Solid

Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data

Recently, the results of a landmark randomized controlled trial showed treatment with tirzepatide (15 mg subcutaneous/week), a dual GLP-1R/GIP receptor (GIPR) agonist, caused an 18% placebo-subtracted weight loss (21% total weight loss) at 72 weeks in people with obesity (6)

GLP-1RAs stimulate insulin secretion in a glucose-dependent manner, therefore, reduce the risk of hypoglycemia

In this study, 2,002 patients were randomized

Nr alt samles i en let overskuelig brugerflade, hvor transaktioner er hurtige, og hjlpen er nr, skabes den form for oplevelse, der gr, at man vender tilbage

This not only supports weight loss but also prevents the rapid blood sugar spikes that can negatively affect your energy levels and metabolism